Abstract:Macrocyclic peptides provide an attractive modality for drug development due to their ability to bind challenging targes, their small size, and amenability to powerful evolution techniques such as phage or mRNA display. While these technologies proved capable of generating and screening extremely large libraries and yielded ligands to already many targets, they often do not identify the best binders within a library due to the difficulty of monitoring performance and controlling selection pressure. Furthermore, only a small number of enriched ligands can typically be characterised due to the need of chemical peptide synthesis and purification prior to characterisation. In this work, we address these limitations by developing a yeast display-based strategy for the generation, screening and characterisation of structurally highly diverse disulfide-cyclised peptides. Analysis and sorting by quantitative flow cytometry enabled monitoring the performance of millions of individual macrocyclic peptides during the screening process and allowed us identifying macrocyclic peptide ligands with affinities in the low micromolar to high picomolar range against five highly diverse protein targets. X-ray analysis of a selected ligand in complex with its target revealed optimal shape complementarity, large interaction surface, constrained peptide backbones and multiple inter- and intra-molecular interactions, rationalising the high affinity and exquisite selectivity. The novel technology described here offers a facile, quantitative and cost-effective alternative to rapidly and efficiently generate and characterise fully genetically encoded macrocycle peptide ligands with sufficiently good binding properties to even therapeutically relevant targets.

mRNA display: ligand discovery, interaction analysis and beyond

Advantages of mRNA display selections over other selection techniques for investigation of protein–protein interactions

Development of Polypeptide-Based Materials Toward Messenger RNA Delivery

Chemical Stability of mRNA/cDNA Complexes: Defining the Limits of mRNA display

The Display Technologies of Molecular Libraries

mRNA display in cell lysates enables identification of cyclic peptides targeting the BRD3 extraterminal domain

Use of Baculovirus MHC/peptide Display Libraries to Characterize T‐cell Receptor Ligands

mRNA Display Pipeline for Protein Biosensor Construction

Recent Advances in Non‐Standard Macrocyclic Peptide Ligand Discovery using mRNA Display

Peptide Phage Display as a Tool for Drug Discovery: Targeting Membrane Receptors

An integrated platform approach enables discovery of potent, selective and ligand-competitive cyclic peptides targeting the GIP receptor

Screening macrocyclic peptide libraries by yeast display allows control of selection process and affinity ranking

Diversification of Phage-Displayed Peptide Libraries with Noncanonical Amino Acid Mutagenesis and Chemical Modification

Extracellular ligand-responsive translational regulation of synthetic mRNAs using engineered receptors

Advances in Studies on Phage Display Systems

Programmable Assembly of Multivalent DNA‐Protein Superstructures for Tumor Imaging and Targeted Therapy

MOrPH-PhD: An Integrated Phage Display Platform for the Discovery of Functional Genetically Encoded Peptide Macrocycles

Efficient Phage Display with Multiple Distinct Non-Canonical Amino Acids Using Orthogonal Ribosome-Mediated Genetic Code Expansion

Advancements in mammalian display technology for therapeutic antibody development and beyond: current landscape, challenges, and future prospects

Application of Yeast Cell-surface Display for Protein Engineering